New insights into the impact of neuro-inflammation in rheumatoid arthritis

Akasbi, 2012, White matter abnormalities in primary Sjogren syndrome, QJM, 105, 433, 10.1093/qjmed/hcr218

Alten, 2014, Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data of up to 4.75 years of treatment, Arthritis Rheumatol, 66, 1987, 10.1002/art.38687

Askling, 2008, The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis, Curr. Opin. Rheumatol, 20, 138, 10.1097/BOR.0b013e3282f4b392

Axford, 2001, Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus, Ann. Rheum. Dis, 60, 106, 10.1136/ard.60.2.106

Barrick, 2010, White matter structural decline in normal ageing: a prospective longitudinal study using tract-based spatial statistics, Neuroimage, 51, 565, 10.1016/j.neuroimage.2010.02.033

Bean, 1999, Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin, J. Immunol, 162, 3504, 10.4049/jimmunol.162.6.3504

Bekkelund, 1995, Quantitative cerebral MR in rheumatoid arthritis, AJNR Am. J. Neuroradiol, 16, 767

Bongartz, 2006, Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials, JAMA, 295, 2275, 10.1001/jama.295.19.2275

Burmester, 2014, Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial, Ann. Rheum. Dis, 10.1136/annrheumdis-2013-204769

Burmester, 2013, Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease, Ann. Rheum. Dis, 72, 517, 10.1136/annrheumdis-2011-201244

Capellino, 2010, Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target, Ann. Rheum. Dis, 69, 1853, 10.1136/ard.2009.119701

Cheng, 2014, Targeting TNF: a therapeutic strategy for Alzheimer's disease, Drug Discov. Today, 10.1016/j.drudis.2014.06.029

Chiu, 2013, Bacteria activate sensory neurons that modulate pain and inflammation, Nature, 501, 52, 10.1038/nature12479

Chou, 2010, Tumor Necrosis Factor Inhibition Reduces the Incidence of Alzheimer's Disease in Rheumatoid Arthritis Patients

Combs, 2001, Beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis, J. Neurosci, 21, 1179, 10.1523/JNEUROSCI.21-04-01179.2001

De Almeida, 2010, Immune dysregulation by the rheumatoid arthritis shared epitope, J. Immunol, 185, 1927, 10.4049/jimmunol.0904002

De Rycke, 2004, Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations, Ann. Rheum. Dis, 63, 1587, 10.1136/ard.2003.017574

Detrait, 2014, Peripheral administration of an anti-TNF-alpha receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-alpha levels and memory deficits in mice, Neurochem. Int, 72, 10, 10.1016/j.neuint.2014.04.001

Diamond, 2011, Mapping the immunological homunculus, Proc. Natl. Acad. Sci. U.S.A, 108, 3461, 10.1073/pnas.1100329108

Doran, 2002a, Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study, Arthritis Rheum, 46, 2287, 10.1002/art.10524

Doran, 2002b, Predictors of infection in rheumatoid arthritis, Arthritis Rheum, 46, 2294, 10.1002/art.10529

Emmer, 2009, Brain involvement in rheumatoid arthritis: a magnetic resonance spectroscopy study, Arthritis Rheum, 60, 3190, 10.1002/art.24932

Fayed, 2010, Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate, Arthritis Res. Ther, 12, R134, 10.1186/ar3072

Feldmann, 2010, Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?, J. Immunol, 185, 791, 10.4049/jimmunol.1090051

Firestein, 2003, Evolving concepts of rheumatoid arthritis, Nature, 423, 356, 10.1038/nature01661

Germano, 2014, Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-alpha antagonists, J. Transl. Med, 12, 77, 10.1186/1479-5876-12-77

Gregersen, 1987, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum, 30, 1205, 10.1002/art.1780301102

Gussew, 2010, Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation, Neuroimage, 49, 1895, 10.1016/j.neuroimage.2009.09.007

Hamed, 2012, Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis, Clin. Rheumatol, 31, 123, 10.1007/s10067-011-1795-1

Harris, 2010, How tumour necrosis factor blockers interfere with tuberculosis immunity, Clin. Exp. Immunol, 161, 1, 10.1111/j.1365-2249.2010.04146.x

Ho, 2001, Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease, Arch. Neurol, 58, 487, 10.1001/archneur.58.3.487

Hull, 2006, Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes, Neurochem. Int, 48, 663, 10.1016/j.neuint.2005.08.013

Hunter, 2007, Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system, J. Neurochem, 100, 1375, 10.1111/j.1471-4159.2006.04327.x

Inan, 2011, Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine, Rheumatol. Int, 31, 1383, 10.1007/s00296-009-1266-z

Jacobs, 2012, INMiND consortium. Noninvasive molecular imaging of neuroinflammation, J. Cereb. Blood Flow Metab, 32, 1393, 10.1038/jcbfm.2012.53

Kaltsonoudis, 2014, Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study, Arthritis Res. Ther, 16, R125, 10.1186/ar4582

Keane, 2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N. Engl. J. Med, 345, 1098, 10.1056/NEJMoa011110

Keystone, 2004, Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial, Arthritis Rheum, 50, 1400, 10.1002/art.20217

King, 2014, Effect of normal aging versus hypertension, abnormal body mass index, and diabetes mellitus on white matter hyperintensity volume, Stroke, 45, 255, 10.1161/STROKEAHA.113.003602

Klareskog, 2008, Immunity to citrullinated proteins in rheumatoid arthritis, Annu. Rev. Immunol, 26, 651, 10.1146/annurev.immunol.26.021607.090244

Lauvsnes, 2014, Loss of cerebral white matter in primary Sjogren's syndrome: a controlled volumetric magnetic resonance imaging study, Eur. J. Neurol, 21, 1324, 10.1111/ene.12486

Lee, 2011, The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia, Arthritis Res. Ther, 13, 211, 10.1186/ar3306

Leombruno, 2009, The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events, Ann. Rheum. Dis, 68, 1136, 10.1136/ard.2008.091025

Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group, N. Engl. J. Med, 343, 1594, 10.1056/NEJM200011303432202

Listing, 2005, Infections in patients with rheumatoid arthritis treated with biologic agents, Arthritis Rheum, 52, 3403, 10.1002/art.21386

MacGregor, 2000, Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins, Arthritis Rheum, 43, 30, 10.1002/1529-0131(200001)43:130::AID-ANR53.0.CO;2-B

Mahdi, 2009, Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis, Nat. Genet, 41, 1319, 10.1038/ng.480

Malaviya, 2012, Rheumatoid arthritis and the era of biologic therapy, Inflammopharmacology, 20, 59, 10.1007/s10787-012-0123-y

Markenson, 1979, Rheumatoid meningitis: a localized immune process, Ann. Intern. Med, 90, 786, 10.7326/0003-4819-90-5-786

McInnes, 2011, The pathogenesis of rheumatoid arthritis, N. Engl. J. Med, 365, 2205, 10.1056/NEJMra1004965

Medeiros, 2007, Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein, J. Neurosci, 27, 5394, 10.1523/JNEUROSCI.5047-06.2007

Mellor, 1959, Cellular origin of rheumatoid factor, J. Exp. Med, 110, 875, 10.1084/jem.110.6.875

Meseguer, 2014, TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins, Nat. Commun, 5, 3125, 10.1038/ncomms4125

Mikuls, 2014, Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis, Arthritis Rheumatol, 66, 1090, 10.1002/art.38348

Morris, 1997, Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis, Pain, 71, 179, 10.1016/S0304-3959(97)03361-7

Nadeau, 1999, Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier, Neuroscience, 93, 1449, 10.1016/S0306-4522(99)00225-0

Ni Mhuircheartaigh, 2013, Trends in serious infections in rheumatoid arthritis, J. Rheumatol, 40, 611, 10.3899/jrheum.121075

Nishioku, 2011, Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis, Neuroscience, 189, 286, 10.1016/j.neuroscience.2011.05.044

Norheim, 2012, Interleukin-1 inhibition and fatigue in primary Sjogren's syndrome–a double blind, randomised clinical trial, PLoS ONE, 7, e30123, 10.1371/journal.pone.0030123

O'Callaghan, 2008, Defining “neuroinflammation.”, Ann. N.Y. Acad. Sci, 1139, 318, 10.1196/annals.1432.032

Ogawa, 1990, Brain magnetic resonance imaging with contrast dependent on blood oxygenation, Proc. Natl. Acad. Sci. U.S.A, 87, 9868, 10.1073/pnas.87.24.9868

Panayi, 2006, Even though T-cell-directed trials have been of limited success, is there reason for optimism?, Nat. Clin. Pract. Rheumatol, 2, 58, 10.1038/ncprheum0094

Parks, 2011, Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain, Eur. J. Pain, 15, 843.e1, 10.1016/j.ejpain.2010.12.007

Ramiro, 2014, Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis, Ann. Rheum. Dis, 73, 529, 10.1136/annrheumdis-2013-204575

Rech, 2013, Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis, Arthritis Rheum, 65, 325, 10.1002/art.37761

Rosenblum, 2011, Anti-TNF therapy: safety aspects of taking the risk, Autoimmun. Rev, 10, 563, 10.1016/j.autrev.2011.04.010

Salliot, 2009, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, Ann. Rheum. Dis, 68, 25, 10.1136/ard.2007.083188

Salmon-Ceron, 2011, Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry, Ann. Rheum. Dis, 70, 616, 10.1136/ard.2010.137422

Scher, 2012, Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis, Arthritis Rheum, 64, 3083, 10.1002/art.34539

Schoels, 2012, Comparative effectiveness and safety of biological treatment options after tumour necrosis factor alpha inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis, Ann. Rheum. Dis, 71, 1303, 10.1136/annrheumdis-2011-200490

Schweinhardt, 2008, Investigation into the neural correlates of emotional augmentation of clinical pain, Neuroimage, 40, 759, 10.1016/j.neuroimage.2007.12.016

Scott, 2010, Rheumatoid arthritis, Lancet, 376, 1094, 10.1016/S0140-6736(10)60826-4

Senaldi, 1996, Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI, J. Immunol, 157, 5022, 10.4049/jimmunol.157.11.5022

Serrats, 2009, How T-cell-dependent and -independent challenges access the brain: vascular and neural responses to bacterial lipopolysaccharide and staphylococcal enterotoxin B, Brain Behav. Immun, 23, 1038, 10.1016/j.bbi.2009.06.004

Skelly, 2013, A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, [corrected] TNF-alpha and IL-6 challenges in C57BL/6 mice, PLoS ONE, 8, e69123, 10.1371/journal.pone.0069123

Smolen, 2014, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Ann. Rheum. Dis, 73, 492, 10.1136/annrheumdis-2013-204573

Sokka, 2009, Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study, Arthritis Res. Ther, 11, R7, 10.1186/ar2591

Steens, 2005, The effect of corticosteroid medication on quantitative MR parameters of the brain, AJNR Am. J. Neuroradiol, 26, 2475

Strangfeld, 2009, Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents, JAMA, 301, 737, 10.1001/jama.2009.146

Symmons, 1997, Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England, Arthritis Rheum, 40, 1955, 10.1002/art.1780401106

Taylor, 2014, Aetiopathology of rheumatoid arthritis, Medicine, 42, 227, 10.1016/j.mpmed.2014.02.010

Teeling, 2012, Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction, Acta Neuropathol, 124, 479, 10.1007/s00401-012-0995-3

Thomson, 2014, Peripheral inflammation is associated with remote global gene expression changes in the brain, J. Neuroinflammation, 11, 73, 10.1186/1742-2094-11-73

Tracey, 2008, Tumor necrosis factor antagonist mechanisms of action: a comprehensive review, Pharmacol. Ther, 117, 244, 10.1016/j.pharmthera.2007.10.001

Tubach, 2009, Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry, Arthritis Rheum, 60, 1884, 10.1002/art.24632

Upadhyay, 2013, Pharmacological modulation of brain activity in a preclinical model of osteoarthritis, Neuroimage, 64, 341, 10.1016/j.neuroimage.2012.08.084

van der Woude, 2010, Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis, Ann. Rheum. Dis, 69, 1554, 10.1136/ard.2009.124537

van Heemst, 2014, HLA and rheumatoid arthritis: how do they connect?, Ann. Med, 46, 304, 10.3109/07853890.2014.907097

van Vollenhoven, 2010, New and future agents in the treatment of rheumatoid arthritis, Discov. Med, 9, 319

Vincent, 1999, Anti-perinuclear factor compared with the so called “antikeratin” antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides, Ann. Rheum. Dis, 58, 42, 10.1136/ard.58.1.42

Wallis, 2004, Granulomatous infectious diseases associated with tumor necrosis factor antagonists, Clin. Infect. Dis, 38, 1261, 10.1086/383317

Wartolowska, 2012, Structural changes of the brain in rheumatoid arthritis, Arthritis Rheum, 64, 371, 10.1002/art.33326

Wegner, 2010, Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis, Arthritis Rheum, 62, 2662, 10.1002/art.27552

Wellcome Trust Case Control Consortium., 2007, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, 447, 661, 10.1038/nature05911

Wendler, 2001, Patients with rheumatoid arthritis adapt differently to repetitive painful stimuli compared to healthy controls, J. Clin. Neurosci, 8, 272, 10.1054/jocn.1999.0775

Weyand, 1990, Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition, J. Clin. Invest, 85, 1051, 10.1172/JCI114535

Wolfe, 2006, Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders, Rheumatology, 45, 1370, 10.1093/rheumatology/kel328

Woolf, 1983, Evidence for a central component of post-injury pain hypersensitivity, Nature, 306, 686, 10.1038/306686a0

Zivadinov, 2013, Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement, Lupus, 22, 675, 10.1177/0961203313486193